Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children
about
Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adultsTreatment for Kaposi's sarcoma in children with HIV-1 infectionTreatment of Kaposi sarcoma in children with HIV-1 infectionPerinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challengesMapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review.Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana.Treatment strategies for Kaposi sarcoma in sub-Saharan Africa: challenges and opportunities.Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low- and middle-income countries in Africa.Building capacity for sustainable research programmes for cancer in Africa.Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study[Skin disorders seen in anatomical pathology laboratory in Lome, Togo].Disseminated cutaneous Kaposi sarcoma in a patient receiving triptolide/tripdiolide for rheumatoid arthritis.Prospective Characterization of the Risk Factors for Transmission and Symptoms of Primary Human Herpesvirus Infections Among Ugandan Infants.Kaposi Sarcoma of Childhood: Inborn or Acquired Immunodeficiency to Oncogenic HHV-8Children with kaposi sarcoma in two southern african hospitals: clinical presentation, management, and outcome.A Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric PopulationVascular and perivascular lesions of skin and soft tissues in children and adolescents.The management of children with Kaposi sarcoma in resource limited settings.Childhood cancer in Africa.High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population.Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.Kaposi sarcoma in HIV-seronegative children presenting to the paediatric oncology ward in The Queen Elizabeth Central Hospital, Blantyre, Malawi during 2002-2014.Triple therapy of vincristine, bleomycin and etoposide for children with Kaposi sarcoma: Results of a study in Malawian children.Stage-stratified approach to AIDS-related Kaposi's sarcoma: implications for resource-limited environments.Kaposi sarcoma in South African children.Pediatric Kaposi sarcoma in context of the HIV epidemic in sub-Saharan Africa: current perspectives.Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related disease
P2860
Q24193874-AA64A877-2B9A-4816-909B-D2460E44676AQ24200722-F536C8A9-33E0-40E6-AEE0-A28036E0EB2DQ24200990-CA2DDBE1-96FB-4EB7-9B96-16EA9DE4D504Q27022471-25E6B334-5887-4BB7-8EB1-EDBC66B7702FQ30251585-ADDA4A10-FFDE-40B0-B57C-B3139BFB4836Q33406437-FAA0E9F3-2E40-4F4A-A406-9E4D4560BD09Q34193400-11CEF920-CA7B-4575-A009-D313CFCAA296Q35360144-212049D9-36D8-4B68-BF5A-2BEE83159B96Q35492988-D6599BB1-A80E-4D38-B741-1F5F8E7D4BA1Q35991165-4253C26D-4125-4921-84E9-E82625E22AFEQ36042729-602315EC-4093-4E74-8C66-6A3CC7200C1BQ36577249-0A9E1150-9D09-462C-BC01-27173B060A43Q37003029-7C9ED0B5-01EF-498C-AAD5-47389B29443CQ37173586-0FDAA004-9765-4392-9754-990A3B0B35C2Q37417301-4B66D134-7EF9-4E5C-B292-C30CC27A0FC2Q37600164-97FFDA3B-F4C5-4187-8761-5BF0C2F9EE9AQ37993922-E76625EB-FA90-4C66-9384-713E580A5507Q38068814-B3C38048-5F63-4702-BD38-8AAFB8944508Q38161444-E96156CC-E831-4633-8FC8-133F6C89C697Q38860797-1AD8C254-279B-4408-9347-1BB77F271EB1Q39437292-F5F21399-59E9-4957-810E-745F28E4628AQ40889421-51123CF8-15D2-4245-B668-6BC1B6E7D112Q41922014-A7E15136-7B5C-4ACF-93F1-757C58619461Q42932040-2DFD7275-2AFE-48D1-9993-A9C987394B41Q44275994-A24B9C0A-88F8-40DD-8AB5-393BE5068F79Q53686620-54D99CA8-D635-44C7-97BD-8AFC27287C3AQ59137002-79D5284C-81D9-4FF8-8A4C-852391BCB805
P2860
Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children
@ast
Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children
@en
type
label
Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children
@ast
Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children
@en
prefLabel
Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children
@ast
Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children
@en
P2093
P2860
P356
P1476
Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children
@en
P2093
Abel Kakuru
Corey Casper
Jackson Orem
Soren Gantt
Victoria Walusansa
P2860
P304
P356
10.1002/PBC.22369
P577
2010-05-01T00:00:00Z